Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells

被引:39
作者
Mahyar-Roemer, M
Fritzsche, C
Wagner, S
Laue, M
Roemer, K
机构
[1] Univ Saarland, Sch Med, Dept Virol, D-66421 Homburg, Germany
[2] Univ Saarland, Sch Med, Dept Anat & Cell Biol, Ctr Electron Microscopy, D-66421 Homburg, Germany
关键词
tumor suppressor; p53; mitochondria; apoptosis;
D O I
10.1038/sj.onc.1207637
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 can eliminate damaged cells through the induction of mitochondria-mediated apoptosis. Recent observations have provided strong evidence that a fraction of total p53 translocates to mitochondria specifically in response to a death stimulus. Unexpectedly, mutant p53, which is expressed at much higher levels than wild type in unstressed cells, is apparently always present at the mitochondria, independent of apoptotic signal. This prompted us to ask whether cell lines with intact p53-dependent apoptosis and cell cycle arrest pathways exist in which the mitochondrial localization of wild-type p53, like that of mutant, is independent of a death stimulus and instead, correlates with the total p53 levels. Here, we document that human HCT116 colorectal carcinoma cells treated with adriamycin or 5-fluorouracil (5FU) can accumulate total p53 to equally high levels, and mitochondrial p53 to proportionate levels, although only 5FU treatment provoked p53-dependent apoptosis. Along the same line, HCT116 derivatives with increased basal p53 levels, and glioblastoma cells with a doxycycline-inducible p53, also revealed proportionate mitochondrial p53 levels, and even unstressed HCT116 cells had some p53 located at the mitochondria. Finally, mitochondrial and total p53 showed distinct post-translational modi. cations. Thus, cell lines exist in which the mitochondrial p53 levels parallel total levels independent of apoptosis.
引用
收藏
页码:6226 / 6236
页数:11
相关论文
共 41 条
  • [1] Attardi LD, 2000, GENE DEV, V14, P704
  • [2] BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
  • [3] Disruption of p53 in human cancer cells alters the responses to therapeutic agents
    Bunz, F
    Hwang, PM
    Torrance, C
    Waldman, T
    Zhang, YG
    Dillehay, L
    Williams, J
    Lengauer, C
    Kinzler, KW
    Vogelstein, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) : 263 - 269
  • [4] Requirement for p53 and p21 to sustain G2 arrest after DNA damage
    Bunz, F
    Dutriaux, A
    Lengauer, C
    Waldman, T
    Zhou, S
    Brown, JP
    Sedivy, JM
    Kinzler, KW
    Vogelstein, B
    [J]. SCIENCE, 1998, 282 (5393) : 1497 - 1501
  • [5] Bunz F, 2002, CANCER RES, V62, P1129
  • [6] P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES
    CAELLES, C
    HELMBERG, A
    KARIN, M
    [J]. NATURE, 1994, 370 (6486) : 220 - 223
  • [7] Essential role for caspase-8 in transcription-independent apoptosis triggered by p53
    Ding, HF
    Lin, YL
    McGill, G
    Juo, P
    Zhu, H
    Blenis, J
    Yuan, JY
    Fisher, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) : 38905 - 38911
  • [8] APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death
    Fortin, A
    Cregan, SP
    MacLaurin, JG
    Kushwaha, N
    Hickman, ES
    Thompson, CS
    Hakim, A
    Albert, PR
    Cecconi, F
    Helin, K
    Park, DS
    Slack, RS
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 155 (02) : 207 - 216
  • [9] Activation of caspases in p53-induced transactivation-independent apoptosis
    Gao, CF
    Tsuchida, N
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (02): : 180 - 187
  • [10] Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
    Gu, W
    Roeder, RG
    [J]. CELL, 1997, 90 (04) : 595 - 606